scispace - formally typeset
M

Massimiliano Bianchi

Researcher at Mario Negri Institute for Pharmacological Research

Publications -  9
Citations -  743

Massimiliano Bianchi is an academic researcher from Mario Negri Institute for Pharmacological Research. The author has contributed to research in topics: Risk factor & Odds ratio. The author has an hindex of 7, co-authored 9 publications receiving 714 citations. Previous affiliations of Massimiliano Bianchi include Pfizer & University of Milan.

Papers
More filters
Journal ArticleDOI

Correlation between semen parameters and sperm aneuploidy rates investigated by fluorescence in-situ hybridization in infertile men.

TL;DR: The risk of a chromosomal aneuploidy in spermatozoa seems to be inversely correlated to sperm concentration and total progressive motility, which strongly suggests the presence of an interchromosomal effect of the cytogenetic rearrangement.
Journal ArticleDOI

The epidemiology of multiple births

TL;DR: The constant frequency of monozygotic (MZ) pregnancies over time and in different geographical areas suggests that the determination of MZ twins is largely unchanged over time, and that a genetic mechanism may have a role.
Journal ArticleDOI

Reliability of ovulation tests in infertile women

TL;DR: Urinary LH was accurate in predicting ovulation with ultrasonography as the standard for detection, but time varied widely; the nadir of BBT predicted ovulation poorly, and the BBT chart was less accurate for confirming ovulation, whereas a single serum progesterone assessment in midluteal phase seemed as effective as repeated serum progestersone measures.
Journal ArticleDOI

Risk factors for urinary incontinence in women.

TL;DR: In the coming years, epidemiological research should focus particularly on the potential differences in the epidemiological characteristics of different types of UI in order to gain insight into the pathogenic mechanisms.
Journal ArticleDOI

Two-year treatment with oral contraceptives in hyperprolactinemic patients.

TL;DR: The data suggest that after 2 years of follow-up, no harmful effect of OC use was observed in a group of young patients using oral contraceptives with hyperprolactinemia and no patient experienced any radiological changes during OC treatment.